245 related articles for article (PubMed ID: 12591741)
1. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Shiraishi T; Alder H; Mimori K; Mori M; Croce CM
Cancer Res; 2002 Apr; 62(8):2258-60. PubMed ID: 11956080
[TBL] [Abstract][Full Text] [Related]
3. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
4. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
[TBL] [Abstract][Full Text] [Related]
5. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
6. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
7. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
[TBL] [Abstract][Full Text] [Related]
8. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
11. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
12. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
13. An opposing view on WWOX protein function as a tumor suppressor.
Watanabe A; Hippo Y; Taniguchi H; Iwanari H; Yashiro M; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2003 Dec; 63(24):8629-33. PubMed ID: 14695174
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
[TBL] [Abstract][Full Text] [Related]
15. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
[TBL] [Abstract][Full Text] [Related]
16. Reversing effect of exogenous WWOX gene expression on malignant phenotype of primary cultured lung carcinoma cells.
Zhou YL; Li YC; Shou F; Liu CQ; Pu Y; Tang H
Chin Med J (Engl); 2010 Mar; 123(5):615-20. PubMed ID: 20367991
[TBL] [Abstract][Full Text] [Related]
17. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
18. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
Sozzi G; Tornielli S; Tagliabue E; Sard L; Pezzella F; Pastorino U; Minoletti F; Pilotti S; Ratcliffe C; Veronese ML; Goldstraw P; Huebner K; Croce CM; Pierotti MA
Cancer Res; 1997 Dec; 57(23):5207-12. PubMed ID: 9393735
[TBL] [Abstract][Full Text] [Related]
19. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
20. Common chromosomal fragile sites and cancer: focus on FRA16D.
O'Keefe LV; Richards RI
Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]